On Verge of Merger, NitroMed Sells Technology in $7.8M Deal April 24, 2009 By Catherine Hollingsworth
NewCo News: Archer Pharma Working on New Version of AD Drug April 23, 2009 By Catherine Hollingsworth
Medarex Sharing up to $225M from Antibody Deal with Merck April 22, 2009 By Catherine Hollingsworth A combination of monoclonal antibodies co-developed by Medarex Inc. and Massachusetts Biologic Laboratories has been licensed to drug giant Merck & Co. Inc. in a deal worth up to $225M. (BioWorld Today)Read More
NewCo News: GliaMed Gets a Facelift as it Moves into Wound Healing April 14, 2009 By Catherine Hollingsworth
